"Accelerating healthcare costs have less to do with hospital and physician services than with surging drug spending ... [Data suggests] advanced therapies increasingly are taking the place of procedure-based care. For example, whereas GLP-1 use increased by more than 700% during a recent five-year period, bariatric surgery rates were flat to declining. Similarly, SGLT2 inhibitor patients more than tripled, while cardiac catheterization volumes declined slightly."  MORE >>